An MKK4 inhibitor
Technical Support & Resources

Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

HRX215

Item No. 41238

Technical Information
Formal Name
N-[2,6-difluoro-3-[[5-(4-pyridinyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]carbonyl]phenyl]-1-propanesulfonamide
CAS Number
2369583-33-3
Synonyms
  • Darizmetinib
  • LN3348
Molecular Formula
C21H17F2N5O3S
Formula Weight
Purity
≥98%
A solid
DMSO: Soluble: ≥ 10 mg/ml
SMILES
FC(C(NS(=O)(CCC)=O)=C1F)=CC=C1C(C(C2=C3)=NNC2=NC=C3C4=CC=NC=C4)=O
InChi Code
InChI=1S/C21H17F2N5O3S/c1-2-9-32(30,31)28-19-16(22)4-3-14(17(19)23)20(29)18-15-10-13(11-25-21(15)27-26-18)12-5-7-24-8-6-12/h3-8,10-11,28H,2,9H2,1H3,(H,25,26,27)
InChi Key
WBNMARNYIFMNEP-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Kinase Resource Center
    Discover Products & Resources for Kinase Research
    • Kinase inhibitors, screening libraries, assay kits, & more
    • Tools to study kinase signaling pathways:
      • Growth factor signaling
      • PI3K/Akt/mTOR
      • MAPKs (ERK, p38, & JNK)
      • JAK/STAT signaling
    • Articles, resources, & advice
    EXPLORE NOW
    Product Description

    HRX215 is an inhibitor of MAP kinase kinase 4 (MKK4; IC50 = 0.02 µM).1 It is selective for MKK4 over JNK1, B-RAF, and MKK7 (IC50s = 7.07, 11.46, and 14.97 µM, respectively). HRX215 (10 mg/kg) decreases hepatocyte apoptosis in a mouse model of liver damage induced by carbon tetrachloride (CCl4). It increases survival and hepatic size and regeneration, decreases intracranial pressure (ICP), and reduces blood ammonia, total bilirubin, and aspartate aminotransferase (AST) levels in a porcine model of partial hepatectomy-induced liver failure when administered at 5 mg/kg.

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Zwirner, S., Rmilah, A.A.A., Klotz, S., et alFirst-in-class MKK4 inhibitors enhance liver regeneration and prevent liver failure. Cell 187(7), 1666-1684 (2024).